OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inadequate Use of Newer Treatments and Glycemic Control by Cardiovascular Risk and Sociodemographic Groups in US Adults with Diabetes in the NIH Precision Medicine Initiative All of Us Research Program
Divya Devineni, Meleeka Akbarpour, Yufan Gong, et al.
Cardiovascular Drugs and Therapy (2022) Vol. 38, Iss. 2, pp. 347-357
Open Access | Times Cited: 10
Divya Devineni, Meleeka Akbarpour, Yufan Gong, et al.
Cardiovascular Drugs and Therapy (2022) Vol. 38, Iss. 2, pp. 347-357
Open Access | Times Cited: 10
Showing 10 citing articles:
2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 856
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 856
Socioeconomic aspects of incretin-based therapy
Thomas Karagiannis, Eleni Bekiari, Απόστολος Τσάπας
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1859-1868
Open Access | Times Cited: 30
Thomas Karagiannis, Eleni Bekiari, Απόστολος Τσάπας
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1859-1868
Open Access | Times Cited: 30
Underuse of GLP-1 receptor agonists in the management of type 2 diabetes despite a favorable benefit-safety profile
André Scheen
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 7, pp. 797-810
Closed Access | Times Cited: 4
André Scheen
Expert Opinion on Drug Safety (2024) Vol. 23, Iss. 7, pp. 797-810
Closed Access | Times Cited: 4
Real-life underuse of SGLT2 inhibitors for patients with type 2 diabetes at high cardiorenal risk
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 13, pp. 100184-100184
Open Access | Times Cited: 9
André Scheen
Diabetes Epidemiology and Management (2023) Vol. 13, pp. 100184-100184
Open Access | Times Cited: 9
Bridging the gap in cardiovascular care in diabetic patients: are cardioprotective antihyperglycemic agents underutilized?
André Scheen
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1053-1062
Closed Access | Times Cited: 8
André Scheen
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 11, pp. 1053-1062
Closed Access | Times Cited: 8
Contemporary use of cardiovascular risk reduction strategies in type 2 diabetes. Insights from the diabetes collaborative registry
Suzanne V. Arnold, Kensey Gosch, Mikhail Kosiborod, et al.
American Heart Journal (2023) Vol. 263, pp. 104-111
Closed Access | Times Cited: 7
Suzanne V. Arnold, Kensey Gosch, Mikhail Kosiborod, et al.
American Heart Journal (2023) Vol. 263, pp. 104-111
Closed Access | Times Cited: 7
KDOQI Commentary on the KDIGO 2022 Update to the Clinical Practice Guideline for Diabetes Management in CKD
Amy K. Mottl, Susanne B. Nicholas
American Journal of Kidney Diseases (2023) Vol. 83, Iss. 3, pp. 277-287
Closed Access | Times Cited: 6
Amy K. Mottl, Susanne B. Nicholas
American Journal of Kidney Diseases (2023) Vol. 83, Iss. 3, pp. 277-287
Closed Access | Times Cited: 6
Type 2 Diabetes and Chronic Kidney Disease: An Opportunity for Pharmacists to Improve Outcomes
Joshua J. Neumiller, Wendy L. St. Peter, Jay H. Shubrook
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1367-1367
Open Access | Times Cited: 1
Joshua J. Neumiller, Wendy L. St. Peter, Jay H. Shubrook
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1367-1367
Open Access | Times Cited: 1
Determinants of glycemic control among persons living with type 2 diabetes mellitus attending a district hospital in Ghana
Alexander Adjei, Kennedy Brightson, Michael Matey Mensah, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0308046-e0308046
Open Access | Times Cited: 1
Alexander Adjei, Kennedy Brightson, Michael Matey Mensah, et al.
PLoS ONE (2024) Vol. 19, Iss. 11, pp. e0308046-e0308046
Open Access | Times Cited: 1
Prescribing Patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Patients with T2DM and ASCVD in South Korea
Yeong Rok Eom, Hajung Joo, Seung Eun Chae, et al.
Research Square (Research Square) (2024)
Open Access
Yeong Rok Eom, Hajung Joo, Seung Eun Chae, et al.
Research Square (Research Square) (2024)
Open Access
